Protein detail
PDLI5
PDZ and LIM domain protein 5 (Enigma homolog) (Enigma-like PDZ and LIM domains protein)
Entry name PDLI5 | UniProt ID | EVMP confidence score 0.60 |
Supporting publications (n) 17 | Transmembrane count | Protein classification Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins |
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30Basic Information
Protein Names
PDZ and LIM domain protein 5 (Enigma homolog) (Enigma-like PDZ and LIM domains protein)
Protein Class (3)
Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins
Protein Function
Predicted intracellular proteins
Ensembl
Entrez Gene Symbol
Gene Synonym (2)
EnhLIM
Gene Description
PDZ and LIM domain 5
Chromosome
4
Position
94451857-94668227
Supporting publications (n)
17
EVMP confidence score
0.60
Fluorescence & Localization
Cell SpecificAdrenal cortex cellsSingle-Nuclei Brain Specificastrocyte
Function & Pathway
Protein Function
Predicted intracellular proteins
Cellular Component (10)
Molecular Function (7)
Biological Process (3)
Reactome (3)
Mediation Categories
Fusion and delivery mediation
Relations & Evidence22
Enzyme-Mediated Modification (7)
7 records.
| Substrate Gene Symbol | Enzyme Gene Symbol | Enzyme UniProt ID | Residue Type | Residue Offset | Modification | Database | References |
|---|---|---|---|---|---|---|---|
| PDLIM5 | MAPK6 | Q16659 | S | 111 | phosphorylation | PhosphoNetworks | |
| PDLIM5 | MAPK6 | Q16659 | S | 137 | phosphorylation | PhosphoNetworks | |
| PDLIM5 | MAPK6 | Q16659 | S | 313 | phosphorylation | PhosphoNetworks | |
| PDLIM5 | MAPK6 | Q16659 | S | 360 | phosphorylation | PhosphoNetworks | |
| PDLIM5 | MAPK6 | Q16659 | T | 417 | phosphorylation | PhosphoNetworks | |
| PDLIM5 | PDPK1 | O15530 | S | 137 | phosphorylation | PhosphoNetworks | |
| PDLIM5 | PDPK1 | O15530 | S | 319 | phosphorylation | PhosphoNetworks |
Ligand-Receptor Signaling (5)
5 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| intracellular | intracellular | LOCATE | |||||
| intracellular | intracellular | ComPPI | |||||
| intracellular | intracellular | GO_Intercell | |||||
| intracellular | intracellular | UniProt_location | |||||
| intracellular | intracellular | OmniPath |
Protein Complex Composition (9)
9 records.
| Component Name | Component Gene Symbols | Component UniProt ID | Stoichiometry | Database | Database IDs | References |
|---|---|---|---|---|---|---|
| ACADSBALADCZIBDUS3LPDLIM5RASA1SARS1 | P13716P20936P45954P49591Q96G46Q96HC4Q9NWV4 | 0:0:0:0:0:0:0 | hu.MAP | |||
| FKBP1APDLIM5SUMO3TAGLN2TAGLN3 | P37802P55854P62942Q96HC4Q9UI15 | 0:0:0:0:0 | hu.MAP2 | |||
| MKNK1PDLIM5TTC3 | P53804Q96HC4Q9BUB5 | 0:0:0 | hu.MAP | |||
| DNAJB12MKNK1PDLIM5TTC3 | P53804Q96HC4Q9BUB5Q9NXW2 | 0:0:0:0 | hu.MAP | |||
| CNN3PDLIM5RWDD2B | P57060Q15417Q96HC4 | 0:0:0 | hu.MAP2 | |||
| PDLIM5RWDD2B | P57060Q96HC4 | 0:0 | hu.MAP2 | |||
| CNN3PDLIM5 | Q15417Q96HC4 | 0:0 | hu.MAP2 | |||
| PDLIM5 | Q96HC4 | 5 | PDB | PDB:2uzc | ||
| MKNK1PDLIM5 | Q96HC4Q9BUB5 | 0:0 | hu.MAP |
Sequence, Structure & Domains
Sequences
Length
596
Mass
63,945
Sequence
MSNYSVSLVGPAPWGFRLQGGKDFNMPLTISSLKDGGKAAQANVRIGDVVLSIDGINAQGMTHLEAQNKIKGCTGSLNMTLQRASAAPKPEPVPVQKGEPKEVVKPVPITSPAVSKVTSTNNMAYNKAPRPFGSVSSPKVTSIPSPSSAFTPAHATTSSHASPSPVAAVTPPLFAASGLHANANLSADQSPSALSAGKTAVNVPRQPTVTSVCSETSQELAEGQRRGSQGDSKQQNGPPRKHIVERYTEFYHVPTHSDASKKRLIEDTEDWRPRTGTTQSRSFRILAQITGTEHLKESEADNTKKANNSQEPSPQLASSVASTRSMPESLDSPTSGRPGVTSLTAAAAFKPVGSTGVIKSPSWQRPNQGVPSTGRISNSATYSGSVAPANSALGQTQPSDQDTLVQRAEHIPAGKRTPMCAHCNQVIRGPFLVALGKSWHPEEFNCAHCKNTMAYIGFVEEKGALYCELCYEKFFAPECGRCQRKILGEVISALKQTWHVSCFVCVACGKPIRNNVFHLEDGEPYCETDYYALFGTICHGCEFPIEAGDMFLEALGYTWHDTCFVCSVCCESLEGQTFFSKKDKPLCKKHAHSVNF
Alternative Products
Event=Alternative splicing; Named isoforms=7; Name=1; IsoId=Q96HC4-1; Sequence=Displayed; Name=2; IsoId=Q96HC4-2; Sequence=VSP_039075, VSP_039076, VSP_039077, VSP_039078; Name=3; IsoId=Q96HC4-3; Sequence=VSP_039206, VSP_039207, VSP_039077, VSP_039078; Name=4; IsoId=Q96HC4-4; Sequence=VSP_039075; Name=5; IsoId=Q96HC4-5; Sequence=VSP_045098, VSP_045099; Name=6; IsoId=Q96HC4-6; Sequence=VSP_039075, VSP_039076, VSP_053796; Name=7; IsoId=Q96HC4-7; Sequence=VSP_039075, VSP_039076, VSP_053797
Alternative Sequence
33..136; LKDGGKAAQANVRIGDVVLSIDGINAQGMTHLEAQNKIKGCTGSLNMTLQRASAAPKPEPVPVQKGEPKEVVKPVPITSPAVSKVTSTNNMAYNKAPRPFGSVS -> AGVQWRNLGSPQPPSPEFKRFSCLSLPSSWDYRHVPPRLANFVFLVETKFPYVGQAGLELPTSGDLPTSASQSAKITGVSHRAWPTLFYTLLFFATIYPEIILY (in isoform 5); 98..206; Missing (in isoform 2, isoform 4, isoform 6 and isoform 7); 98..117; GEPKEVVKPVPITSPAVSKV -> KTQVTNNPGTVKIPPKRPPR (in isoform 3); 118..240; Missing (in isoform 3); 137..596; Missing (in isoform 5); 237; G -> GKIPPKR (in isoform 2, isoform 6 and isoform 7); 307..337; NNSQEPSPQLASSVASTRSMPESLDSPTSGR -> KEKIPLHVFSPKYTKLRDWHHEVSARALNVQ (in isoform 2 and isoform 3); 307; N -> KFDSALEDLPKSGPHPPATPQVLTIGSQVATLSKVATTYSSLSSSTGNVEDSFEGFRNFSTFSSPARYSAAVLSSAAATVSAVIATKTRLYTPERYHSLLDALCISPVSKPLAFSYLQSSRKSTGSIHVKKTS (in isoform 6); 338..596; Missing (in isoform 2 and isoform 3); 587..596; Missing (in isoform 7)
3D Structural Models
Turn
413..415; 441..443
Helix
22..24; 38..41; 63..71; 468..474
Beta Strand
3..12; 16..21; 26..33; 49..53; 75..82; 409..411; 419..423; 431..434; 437..439; 447..449; 454..456; 458..463
3D Structure
NMR spectroscopy (1); X-ray crystallography (2)
Domain & Motif Annotations
Compositional Bias
134..143; Polar residues; 144..165; Low complexity; 205..219; Polar residues; 226..237; Polar residues; 258..273; Basic and acidic residues; 293..304; Basic and acidic residues; 305..335; Polar residues; 361..381; Polar residues
Domain (FT)
2..85; PDZ; 418..477; LIM zinc-binding 1; 477..536; LIM zinc-binding 2; 536..596; LIM zinc-binding 3
Region
121..165; Disordered; 196..240; Disordered; 255..340; Disordered; 354..381; Disordered
Clinical Relevance
Supporting Publications17
| PMID | Title | Related sentences |
|---|---|---|
| 26826536 | [Cardiovascular risk study in patients with renin-angiotensin system blockade by means of the proteone of circulating extracellular vesicles]. | No related sentences available |
| 32854315 | Proteomic Profiling of Extracellular Vesicles Derived from Cerebrospinal Fluid of Alzheimer's Disease Patients: A Pilot Study. | Recent studies have highlighted the importance of Aβ and tau-containing extracellular vesicles (EVs) in AD. |
| 33592500 | A Proteomic Approach to Understand the Clinical Significance of Acute Myeloid Leukemia-Derived Extracellular Vesicles Reflecting Essential Characteristics of Leukemia. | No related sentences available |
| 34064677 | Ubiquinone Metabolism and Transcription HIF-1 Targets Pathway Are Toxicity Signature Pathways Present in Extracellular Vesicles of Paraquat-Exposed Human Brain Microvascular Endothelial Cells. | No related sentences available |
| 36064647 | Systemic proteomics and miRNA profile analysis of exosomes derived from human pluripotent stem cells. | No related sentences available |
| 36146834 | Human Cytomegalovirus Modifies Placental Small Extracellular Vesicle Composition to Enhance Infection of Fetal Neural Cells In Vitro. | No related sentences available |
| 36497184 | Oxidative Stress and Extracellular Matrix Remodeling Are Signature Pathways of Extracellular Vesicles Released upon Morphine Exposure on Human Brain Microvascular Endothelial Cells. | No related sentences available |
| 37322475 | Comprehensive profiling of extracellular vesicles in uveitis and scleritis enables biomarker discovery and mechanism exploration. | No related sentences available |
| 38113368 | In-Depth Proteome Profiling of Small Extracellular Vesicles Isolated from Cancer Cell Lines and Patient Serum. | No related sentences available |
| 38207106 | Proteomic, Metabolomic, and Fatty Acid Profiling of Small Extracellular Vesicles from Glioblastoma Stem-Like Cells and Their Role in Tumor Heterogeneity. | No related sentences available |
Page 1 of 2Next